Printer Friendly

Nonphotodynamic Roles of Methylene Blue: Display of Distinct Antimycobacterial and Anticandidal Mode of Actions.

1. Introduction

In this era of antibiotics, many efficient drugs have been developed or are under development to treat various infectious diseases. But the real challenge is to surmount the parallel evolution of drug resistance, which is also emerging at similar pace [1, 2]. Cumulatively, both bacterial and fungal infections are responsible for the major cause of mortality in the world. Among bacterial infections, tuberculosis (TB) is a frequent infectious disease in human, caused by Mycobacterium tuberculosis (MTB) and a brutal killer bacterium responsible for millions of deaths annually around the globe [2]. Similarly, among fungal infections, due to its opportunistic nature, Candida albicans is one of the major fungal pathogens that has emerged in the immunocompromised conditions such as AIDS, diabetes, organ transplantation, burn [3, 4], and coinfection with organisms such as MTB [2]. The length and complexity of currently available chemotherapy for TB and fungal infections are far from satisfactory due to high costs, toxicity, and emergence of multidrug resistance (MDR) strains of MTB and C. albicans which is causing a menace to the current therapeutic regime. Hence, the need for the alternative therapeutics with efficiency to restrain the growth of both microbes is indispensable.

Methylene blue (MB) is widely used as dye in variety of biological sciences applications [5, 6]. MB has been used for diagnostic procedures and the treatment of multiple disorders, including methemoglobinemia, cyanide, and carbon monoxide poisoning, and is considered to be nontoxic [7]. Moreover, due to its light absorbing nature, MB has been extensively used in photodynamic therapy [8]. Previously we have demonstrated the antifungal potential of MB against C. albicans [9]. This study uncovers additional targets of MB in C. albicans and not only reveals deeper insights into the anticandidal mechanisms but also provided sufficient clues to decipher its antimycobacterial potential against the surrogate model of MTB, Mycobacterium smegmatis. We explored that MB is an efficient antimicrobial agent against C. albicans and Mycobacterium with some common (membrane disruption, oxidative stress, and biofilm inhibition) and distinct (cell surface phenotypes, DNA damage, and cell adherence) mechanisms of action.

2. Materials and Methods

2.1. Media and Growth Conditions. All media chemicals YPD (Yeast Extract Peptone Dextrose) for C. albicans and oleic acid/albumin/dextrose/catalase (OADC) for Mycobacterium, tetrazolium salt 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), were purchased from Himedia, Mumbai. Middlebrook 7H9 broth was purchased from BD Biosciences (USA). Calcofluor white (CFW), diethyl pyrocarbonate (DEPC), 4-morpholinepropanesulfonic acid (MOPS), tri-reagent, DNase, and ethidium bromide (EtBr) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Fresh C. albicans (SC5314) was cultured in YPD media (2% dextrose, 2% peptone, and 1% yeast extract) overnight at 30[degrees] C before each experiment. Similarly, Mycobacterium smegmatis, [mc.sup.2]155, was used as a parent wild-type strain for all the experiments. Bacteria were maintained on 7H10 agar supplemented with 10% (v/v) oleic acid/albumin/dextrose/catalase (OADC; BD Difco) and grown in Middlebrook 7H9 (BD Biosciences) broth supplemented with 0.05% Tween-80 (Sigma), 10% albumin/dextrose/catalase (ADC; BD Difco), and 0.2% glycerol (Fischer Scientific) in 100 ml flasks (Schott Duran) and incubated at 37[degrees]C till the [OD.sub.600] is equal to 1.0. Stock cultures of log phase cells were maintained in 30% glycerol and stored at -80[degrees]C.

2.2. Minimum Inhibitory Concentration (MIC). MIC for Mycobacterium was determined by Resazurin microtiter assay (REMA) plate method [10]. Briefly, 100 [micro]L of Middlebrook 7H9 broth was placed at each well of the 96-well microtiter plate following the addition of MB with the remaining media and then subsequently it was serially diluted by 1:2. 100 [micro]L of cell suspension (in normal saline to an [O.D.sub.600] 0.1) was added to each well of the plate. Plates were incubated at 37[degrees]C for 48 hours. After 48 hours 30 [micro]l of 0.02 per cent resazurin sodium salt solution was added to each well and again incubated for further 2 hours at 37[degrees] C.

2.3. Static-Cidal Assay. For the static-cidal assay, 3 replicate assay cultures were prepared and C. albicans and M. smegmatis at 0.1 [OD.sub.600] were seeded to fresh media supplemented with MB at its MIC values and incubated at 30[degrees]C and 37[degrees]C, respectively. Next day, 100 [micro]l of the same culture was inoculated into the fresh media without MB and incubated for another 24 hrs and [OD.sub.600] was measured with spectrophotometer.

2.4. Colony Morphology. For C. albicans, colony morphology was determined by plating the cells on YPD agar plates in presence of subinhibitory concentration of MB (25 [micro]g/mL) as determined by growth curve experiments (data not shown) and incubated at 30[degrees]C for 2 days. Postincubation, images of the individual colonies were taken at 40x magnification. For M. smegmatis, colony morphology was determined as described earlier [11,12]. Briefly, cells were plated on MB7H10 agar plates supplemented with 10% OADC (BD Difco) and incubated at 37[degrees] C for 2 to 4 days in presence of subinhibitory concentration of MB (3.9 [micro]g/mL) as determined by growth curve experiments (data not shown). Postincubation, images of the individual colonies were taken at 10x magnification.

2.5. Relative Sedimentation. Cell sedimentation was measured spectrophotometrically as described earlier [13]. Briefly, overnight culture of C. albicans was inoculated to 0.1 [OD.sub.600] to both control and MB treated cells and allowed to grow till the [OD.sub.600] reaches 1.0. The [OD.sub.600] from each untreated and treated cultures were measured at each min till 30 minutes. For M. smegmatis, cell sedimentation assay was performed as described elsewhere [11, 12]. Cultures at [OD.sub.600] 1.0-1.4 of the control and cells treated with MB at its subinhibitory concentration (3.9 [micro]g/mL) in Middlebrook media supplemented with ADC were adjusted to OD590 1.0 and kept unshaken at 37[degrees]C. At 3 and 22 h, the upper 1 ml was removed for [OD.sub.590] measurements. Sedimentation rates were measured by recording the differences in growth from zero time point to 30 min per unit time interval and calculated as described in figure legends.

2.6. Propidium Iodide Uptake. Propidium iodide (PI) is membrane impermeable dye and is widely used to differentiate cells that have damaged or nonintact plasma membranes from healthy cells [12, 14]. To evaluate the effect of MB on the plasma membrane of C. albicans (approximately 1 x [10.sup.3] CFUs/ml) and M. smegmatis, cells were obtained from exponential phase and exposed to MB (25 [micro]g/ml and 3.9 [micro]g/ml, resp.) for 3 hours at 30[degrees]C with gentle shaking. Subsequently, cells were harvested and incubated with 50 [micro]g/ml PI for 15 min in the dark; 10 [micro]l cellular suspension was transferred to a glass slide, covered with coverslip, and examined under fluorescence microscope at 40x (Coslab fluorescence microscope).

2.7. ROS Estimation. Cells were stained with DCFDA to detect the presence of reactive oxygen species (ROS) as described elsewhere [15]. C. albicans cells were grown in YPD overnight in presence of MB at 30[degrees]C. After staining with 0.1 [micro]g/mL DCFDA for 15 min, the stained cells were collected and washed thrice with PBS for 5 min. Cells were visualized for presence of ROS by detecting fluorescence (Coslab fluorescence microscope) at magnification 40x. For M. smegmatis cells were grown in Middlebrook 7H9 broth in the absence (control) and presence of MB and allowed to grow until it reaches 0.8-0.9 OD. The cells were harvested at 13,000 rpm 15 min and resuspended in 1 ml of media and grown for 1h at 37[degrees]C (Starvation Stress) with shaking. Cells were harvested, washed with PBS 7.4 pH, and resuspended in the same buffer in such a way that each 1 ml of PBS pH 8.5 buffer contains 3 x was added in cell suspension with the final concentration of 10 mM and incubated at 37[degrees]C for 30 min with continuous shaking. After washing with PBS buffer pH of 7.4 and resuspension in the same buffer, the cells were observed in fluorescence microscope with the excitation and emission value at 488 nm, slit 5 nm and 540 nm, and slit 10 nm, respectively, at 40x. 3mM H2O2 was used as positive control and ascorbic acid (AA) at 2.5 mM as antioxidant [12].

2.8. D API Staining. Cells were stained with DAPI to detect DNA damage as described elsewhere [12, 14]. The cells of exponential phase were inoculated and grown overnight in presence of MB at 30[degrees]C for Candida and 37[degrees]C for Mycobacterium and DNA damage was identified by staining with 0.1 [micro]g/mL DAPI for 15 min. The stained cells were collected and washed twice with 1% BSA in PBS for 5 min followed by a five-minute rinse in 0.1% BSA in PBS. Cells were visualized at 100x for C. albicans and 40x for M. smegmatis with Coslab fluorescence microscope.

2.9. Biofilm and Biomass Estimation. Candida biofilms were checked on silicon sheet placed in the polystyrene surface of 96-well plates for CFW staining (visualization) and 12-well plates for biomass estimation. An overnight culture was prepared and cell suspension of 1 x [10.sup.7] cells [ml.sup.-1] was made in PBS and 100 [micro]L was inoculated in each well. The plates were incubated at 37[degrees]C for 90 min to adhere the cells on the surface. The wells were gently washed 2-3 times with PBS after 90 min to remove the nonadhered cells. The biofilm was formed by suspending 200 [micro]L of YPD medium along with subinhibitory concentrations of MB (25 [micro]g/ml) and one control without MB to each well of adhered cells to polystyrene 96-well plates and the plates were incubated at 37[degrees]C for 24 h. After incubation, wells were washed to remove any planktonic cells and stained with CFW to visualize the formation of biofilms under light microscope. For biomass estimation, the preweighed dried silicon sheets were weighed again after biofilm formation and differences in weights were calculated [13, 16].

M. smegmatis biofilm-forming potential was qualitatively and quantitatively analyzed using the microtiter plate method as described elsewhere [11,12]. Briefly, M. smegmatis cultures were grown overnight at 37[degrees]C in Middlebrook media, followed by transfer of 100 [micro]l of the media in each well of the 96-well plate with or without the addition of the drug. Cultures that had reached an [OD.sub.600] of 0.1 were diluted (1: 100) using Middlebrook media and 100 [micro]l of each diluted culture was pipetted into each well of a 96-well flat-bottom microtiter plate and incubated at 37[degrees]C for 48 h. The wells were rinsed with water, and 50 [micro]l of 5 mg/ml of MTT was added. Plates were incubated at 37[degrees] C for 5hrs, followed by washing with PBS two times and addition of 100 [micro]l DMSO. The OD570 was measured using a spectrophotometer. For qualitative assay, M. smegmatis biofilms were formed in Middlebrook 7H9 broth in the absence (control) and presence of MB (3.9 [micro]g/ml) at [OD.sub.600] of 1.0 and incubated for 48 h at 37[degrees]C in 12-well plate containing coverslips. The preweight coverslips were rinsed with distilled water and the dry weight was measured after biofilm formation by calculating the difference. 1% CFW was added to each coverslip, and incubated for 10 min at room temperature. Then coverslips were rinsed with PBS and visualized under fluorescent microscope at 40x.

2.10. Cell Adherence. For cell adhesion assay on polystyrene plate, the same procedure (as mentioned in biofilm-forming quantitative assay) was followed except that primarily treated and nontreated cells were grown till [OD.sub.600] 1.0 and after washing the nonadhered cells, they were directly quantified with MTT. On the other hand, adherence was also estimated on human oral epithelial cells as described earlier [11-13]. Briefly, cells were grown for 24 h at 37[degrees] C and resuspended in 2 ml of sterile PBS (pH 6.8) and washed twice by centrifugation (3000 xg, 5 min for C. albicans, and 10,000 xg, 15 min for Mycobacterium). Author voluntarily donated the epithelial cells via soft scraping of the cheek mucous membrane with sterile cotton swabs, gently stirred, and washed twice with PBS. Adherence assays were developed by mixing 1 ml of each suspension in a test tube and incubated in the presence of MB at 37[degrees] C under gentle stirring for 2h. After incubation, two drops of 0.4% of trypan blue solution and carbol fuchsin (3-5 [micro]l) for Mycobacterium only were added to each tube and the mixture was gently shaken. Stained suspensions were examined under light microscopy at 40x and 100x magnifications, respectively.

2.11. RNA Isolation and RT-PCR. For RNA isolation [13,17], the cells were diluted into 50 ml fresh broth at OD600 of 0.1 ([10.sup.6] cells [ml.sup.-1]) in absence (control) and presence of MB and grown till OD600 of 1.0. RNA isolation was performed by Trizol method and reverse transcriptase (RT) PCR was performed as described in the RevertAid H Minus kit (Invitrogen). Briefly, 5 [micro]g isolated RNA was DNase treated at 37[degrees]C for 30 min and reaction was terminated by adding 1 [micro]l of 25 mM EDTA and incubated at 65[degrees]C for 60 min. RNA was subsequently primed with oligo (dT) 18 for cDNA synthesis at 42[degrees] C for 60 min. Reverse transcription reaction was terminated by heating at 70[degrees]C for 5 min. The synthesized cDNA product (2 [micro]l) was directly used for PCR amplification reaction (50 [micro]l) using gene specific forward and reverse primers (Table 1). The amplified products were gel electrophoresed and the densities of bands (for genes of interest) were measured and quantified by normalizing to that of the constitutively expressed actin gene (ACT1) in C. albicans and 16S gene in Mycobacterium.

2.12. Statistical Analysis. All experiments were performed in triplicate (n = 3). The results were reported as mean [+ or -] standard deviation (SD) and analyzed by using Student's i-test in which P < 0.05 was considered as statistically significant.

3. Results and Discussion

3.1. MB Is Fungistatic and Mycobacteriostatic in Nature. In our previous study, we have shown that the in vitro antifungal activity of MB is at 100 [micro]g/ml [9]. Here we extended our observation in another frequent human pathogen, Mycobacterium. We observed that the antimycobacterial activity of MB at 15.625 [micro]g/ml was sufficient enough to impede the growth of M. smegmatis (Figure 1(a)). Interestingly, MB shows its antimycobacterial effect, at much lower MIC value in comparison to its antifungal MIC which was observed at 100 [micro]g/ml. Further, we have checked whether the antimicrobial effect of MB is cidal or static in nature against both the tested organisms. We found that the antimicrobial nature of MB against Candida as well as Mycobacterium was static in nature (Figure 1(b)).

3.2. MB Leads to Impaired Cell Surface Phenotypes in Mycobacterium but Not C. albicans. Membrane disruptive effect of MB in C. albicans as demonstrated previously [9] prompted us to examine the various cell surface phenotypes more closely. For this, colony morphologies of both untreated and treated (MB) C. albicans cells were observed. Figure 2(a) depicts that there is no appreciable difference in the colony morphology even in the presence of MB except the fact that the colony size was smaller in comparison to control cells. That cell surface phenotypes were not affected in C. albicans became further apparent when we used a spectrophotometric based assay to measure sedimentation rates of the cells. Again, the rate of sedimentation of cells grown in the presence of MB showed no considerable difference with respect to the control (Figure 2(b)). Interestingly, colony morphology of M. smegmatis appeared as smooth with well-defined borders in the control cells where as in MB treated cells colony appeared as rough and dry with undefined borders (Figure 2(c)). Similarly, the cell sedimentation rate was enhanced in presence of MB for mycobacterial cells (Figure 2(d)). Some studies suggest that this alteration in the cell surface properties can be due the presence of surface antigens, that is, glycopeptidolipids also known as glycolipids [18,19] in Mycobacterium sp., respectively. Thus, it would be interesting to study the glycolipids level in response to MB. Since MTB comprises unique cell envelope components due to the presence of complex lipids that render its drug resistance and pathogenicity [20], altered cell surface phenotypes due to MB are crucial as they may lead to modifications in the cell wall components that could in turn affect cell interactions and various other linked attributes. Further intricate studies are needed to find the reasons for the observed defects in phenotypes.

3.3. MB Induced Membrane Perturbation Is Energy Dependent. Next, we studied whether the membrane disruptive effect of MB as observed from previous study [14] was energy dependent or not. ATP is known to provide energy in the translocation of the molecule surpassing the membrane. Sodium azide is a known ATP blocker, which diminishes the amount of ATP by targeting the cytochrome-c oxidase and binding in the reduction site of oxygen between the heme a3 iron and CuB region [21-23]. To confirm that the membrane disruptive action of MB is energy dependent, a PI uptake assay was performed with sodium azide treated cells in the presence of MB. PI is a known fluorescent dye which passes through membrane only in conditions like disruption, damage, or any stress and binds to the nucleic acids [14]. We observed that for C. albicans and M. smegmatis, the cells that were not treated by sodium azide, PI uptake was efficient and showed fluorescence in presence of MB depicting injured membrane. However, in the cells treated with sodium azide no cell was stained with PI (Figure 3). This result not only confirmed our previous hypothesis of membrane disruption in C. albicans by MB but also establishes that membrane disruption by MB is energy dependent. Furthermore, this observation also hold true for Mycobacterium when similar experiment was performed. Thus, these findings suggest that energy is indispensable for the membrane disruptive effect of MB in both C. albicans and Mycobacterium.

3.4. MB Induces Oxidative Stress. Previously, we have suggested that the antifungal action of MB could be due to the altered redox status in C. albicans [9]. Moreover, MB has been used in triggering cellular redox metabolism in human derived endothelial cells [24]. Therefore, we extended our observations and confirmed this effect of MB against both Candida and Mycobacterium by demonstrating the augmentation of the ROS generation. DCFDA is an oxidant sensitive probe which shows green fluorescence upon ROS generation. We explored that MB treated cells showed enhanced level of fluorescence when compared to the untreated cells similar to the cells exposed to hydrogen peroxide. Moreover, the formation of ROS was reverted in presence of antioxidant (AA) to the MB treated cells (Figure 4). During infection, human pathogens must surmount with diverse host-mediated stresses, especially with the antimicrobial properties of macrophages. Macrophages generate antimicrobial reactive oxygen and nitrogen species (ROS and RNS) via NADPH oxidase ([NOX2/gp91.sup.phox]) and inducible nitric oxide synthase [25]. Thus, MB leading to oxidative stress in both tested human pathogens could be further exploited for therapeutic purposes.

3.5. MB Induces DNA Damage in Mycobacterium but Not C. albicans. ROS generation leading to oxidative damage is well known for the cause of DNA damage [26]. Moreover, enhanced ROS generation as demonstrated from this study in both the pathogens necessitated exploring the DNA damage in response to MB. To access whether ROS generation leads to the DNA damage in Candida and Mycobacterium, spot assay was performed using EtBr, a known DNA damaging agent, at a concentration which shows no growth defect in Candida cells. We observed that C. albicans showed no sensitivity regardless of the presence of MB (Figure 5(a)). However, when similar experiment was performed with Mycobacterium cells, we observed sensitivity with MB in the presence of EtBr (Figure 5(a)). To further confirm this preliminary data, DAPI staining was performed which is a fluorescent dye that preferentially binds to the AT site between the minor groove of damaged DNA. Our results demonstrate that in C. albicans no difference in the DAPI staining was observed in the MB treated cells when compared to the untreated cells (Figure 5(b)). Interestingly, we found that the Mycobacterium cells treated with MB showed blue fluorescence in contrast to no fluorescence in untreated control which could be linked with DNA damage (Figure 5(b)). Despite the fact that the mechanism of DNA damage is not fully elucidated in MTB it is well established that DNA repair mechanisms are necessary for its persistence in the host [27, 28]. These observations confirmed that MB can specifically target the DNA repair response machinery against Mycobacterium but not C. albicans despite generation of enhanced ROS in both pathogens.

3.6. MB Inhibits Biofilm Formation. Biofilms are a defensive forte for microorganisms; within its vicinity they are safe from antibiotic treatment and can create a source of persevering infection. The previously reported data [9] that suggested the inhibition of morphogenetic switching through MB treatment compelled us to study virulence factor, that is, biofilm formation. The biofilm formation was studied by three independent methods, namely, quantitation of biofilm through MTT assay depicting metabolic activity, visualization of CFW stained cells, and dry mass estimation. All the three methods suggest that biofilm formation was significantly suppressed in the presence of MB in both the pathogens (Figures 6(a) and 6(b)). Thus, MB is a potent inhibitor of biofilm formation in both C. albicans and M. smegmatis.

3.7. MB Inhibits Cell Adherence in Mycobacterium but Not C. albicans. Preliminary to the biofilm formation, the cells have to be attached efficiently to the surface. Thus, microbial cells need to adhere before forming the mature biofilms, thereby making cell adherence another contributing factor in governing virulence [11, 29]. Firstly, we studied the cell adherence of C. albicans on microtiter polystyrene surface and human epithelial cells in the presence of MB. Expectedly, the cell adherence was inhibited when observed in polystyrene microtiter surface (Figure 7(a) upper panel). Interestingly, despite having clear effect on the disruption of hyphal formation, we found that MB showed no effect on the adhesive properties of C. albicans and the fungal cells could adhere to the human epithelial cells (Figure 7(a) lower panel). When similar experiments were performed for Mycobacterium, considerably diminished levels of adherence to both the microtiter polystyrene surface and human epithelial cells were observed when treated with MB (Figure 7(b)). Since alteration in cell property is also linked to biofilm formation and adherence and as a known fact of matter outer portion of nontuberculous mycobacteria (NTM) are attached to the glycolipids [30, 31], hence change in the composition of glycolipids could change the formation of biofilm or adherence of mycobacterium. These observations led us to believe that MB is potent inhibitor of cell adherence only in Mycobacterium and not C. albicans.

3.8. Differential Expression of Genes in Response to MB. The disrupted phenotypes reported in this study were validated by RT-PCR. Mycolic acid is a major constituent of the mycomembrane and hallmark of mycobacteria having crucial role in the permeability of the membrane [32]. In our study, we found downregulated ACCD4 gene in response to MB (Figure 8) which is essential for the synthesis of mycolic acid and survival of M. smegmatis [33]. Similarly, in Mycobacterium, catalase-peroxidase (KatG) is an important protein responsible for activation of the isoniazid. It is already known that the level of KatGp is elevated in oxidative stress [34]. Concomitant with this, we found an upregulation of KatG gene in Mycobacterium when treated with MB (Figure 8). Similarly, we found the downregulation in the LigA gene (Figure 8) which is known for its activity in DNA repair and its replication [35]. GPL is a gene responsible for the formation of biofilm, colony morphology, and sliding motility [36, 37]. In our study, we found that GPL is downregulated in presence of MB (Figure 8) which was consistent with MB inhibiting the formation of biofilm and colony morphology alteration.

In Candida, hyphal wall protein 1 (Hwp1p) is an important factor to show virulence expression like morphogenetic switching and biofilm formation [38]. We have found that HWP1 gene was downregulated in Candida cells when treated with MB (Figure 8). Superoxide dismutase (SOD2) gene is an important gene responsible for the protection against oxidative stress [39]. Through RT-PCR, it was confirmed that SOD2 gene was downregulated in C. albicans when treated with MB (Figure 8). Niemann-Pick C2 (NPC2) gene is involved in sterol transportations through protein membrane interaction [40]. It was found that NPC2 gene was downregulated when treated with MB (Figure 8) which was consistent with the MB induced membrane disruption. Thus, all the RT-PCR results showed good correlation with the MB induced disrupted phenotypes in Mycobacterium as well as C. albicans.

4. Conclusion

Given the limited number of available antifungal and antimycobacterial therapies with concomitant increase in drug resistance, the demand for the search of new, safe, and effective antifungal and anti-TB treatments are inevitable. Considering the fact that MB is FDA approved dye that is already used for various therapeutic options, the distinct antifungal and antimycobacterial mechanisms of MB (Figure 9) presented in this study will aid in comprehending further studies on MB to be exploited as promising drug for future.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors' Contributions

Rahul Pal and Moiz A. Ansari equally contributed to this work.


The authors are grateful to Joseph Heitman and Sarman Singh for providing C. albicans (SC5314) and M. smegmatis (mc2155) reference strains as generous gifts, respectively. They also thank Rajendra Prasad, Dean, Faculty of Science, Engineering and Technology, for encouragement.


[1] J. Tanwar, S. Das, Z. Fatima, and S. Hameed, "Multidrug resistance: an emerging crisis," Interdisciplinary Perspectives on Infectious Diseases, vol. 2014, Article ID 541340, 7 pages, 2014.

[2] H. Nikaido, "Multidrug resistance in bacteria," Annual Review of Biochemistry, vol. 78, pp. 119-146, 2009.

[3] S. Singh, Z. Fatima, and S. Hameed, "Predisposing factors endorsing Candida infections," Infezioni in Medicina, vol. 23, no. 3, pp. 211-223, 2015.

[4] V. Polesello, L. Segat, S. Crovella, and L. Zupin, "Candida infections and human defensins," Protein & Peptide Letters, vol. 24, no. 8, 2017.

[5] Q. Lu, Y. Sun, D. Tian, S. Xiang, and L. Gao, "Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp," Mycopathologia, vol. 182, no. 11-12, pp. 1037-1043, 2017.

[6] G. Dutta and P. B. Lillehoj, "An ultrasensitive enzyme-free electrochemical immunosensor based on redox cycling amplification using methylene blue," Analyst, vol. 142, no. 18, pp. 3492-3499, 2017.

[7] C. R. Sewell and M. P. Rivey, "A case report of benzocaine-induced methemoglobinemia," Journal of Pharmacy Practice, 2017.

[8] J. P. Tardivo, A. Del Giglio, C. S. De Oliveira et al., "Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications," Photodiagnosis and Photodynamic Therapy, vol. 2, no. 3, pp. 175-191, 2005.

[9] M. A. Ansari, Z. Fatima, and S. Hameed, "Antifungal action of methylene blue involves mitochondrial dysfunction and disruption of redox and membrane homeostasis in C. albicans," The Open Microbiology Journal, vol. 10, pp. 12-22, 2016.

[10] A. K. Gupta, V. P. Reddy, M. Lavania et al., "JefA (Rv2459), a drug efflux gene in Mycobacterium tuberculosis confers resistance to isoniazid & ethambutol," Indian Journal of Medical Research, vol. 132, no. 8, pp. 176-188, 2010.

[11] R. Pal, S. Hameed, S. Sharma, and Z. Fatima, "Influence of iron deprivation on virulence traits of mycobacteria," The Brazilian Journal of Infectious Diseases, vol. 20, no. 6, pp. 585-591, 2016.

[12] S. Hans, S. Sharma, S. Hameed, and Z. Fatima, "Sesamol exhibits potent antimycobacterial activity: Underlying mechanisms and impact on virulence traits," Journal of Global Antimicrobial Resistance, vol. 10, pp. 228-237, 2017.

[13] M. A. Ansari, Z. Fatima, and S. Hameed, "Anticandidal effect and mechanisms of monoterpenoid, perillyl alcohol against candida albicans," PLoS ONE, vol. 11, no. 9, Article ID e0162465, 2016.

[14] M. A. Ansari, Z. Fatima, and S. Hameed, "Cellular energy status is indispensable for perillyl alcohol mediated abrogated membrane transport in Candida albicans," ADMET and DMPK, vol. 5, no. 2, pp. 126-134, 2017.

[15] V. Saibabu, S. Singh, M. A. Ansari, Z. Fatima, and S. Hameed, "Insights into the intracellular mechanisms of citronellal in Candida Albicans: Implications for reactive oxygen species-mediated necrosis, mitochondrial dysfunction, and DNA damage," Journal of the Brazilian Society of Tropical Medicine, vol. 50, no. 4, pp. 524-529, 2017.

[16] J. Chandra, D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum, "Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance," Journal of Bacteriology, vol. 183, no. 18, pp. 5385-5394, 2001.

[17] G. M. Rodriguez, M. I. Voskuil, B. Gold, G. K. Schoolnik, and I. Smith, "ideR, an essential gene in Mycobacterium tuberculosis: Role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response," Infection and Immunity, vol. 70, no. 7, pp. 3371-3381, 2002.

[18] A. Lemassu, V V. Levy-Frebault, M.-A. Laneelle, and M. Daffe, "Lack of correlation between colony morphology and lipooligosaccharide content in the Mycobacterium tuberculosis complex," Journal of General Microbiology, vol. 138, no. 7, pp. 1535-1541, 1992.

[19] G. B. Fregnan, D. W. Smith, and H. M. Randall, "A mutant of a scotochromogenic Mycobacterium detected by colony morphology and lipid studies," Journal of Bacteriology, vol. 83, pp. 828-836, 1962.

[20] M. Llorens-Fons, M. Perez-Trujillo, E. Julian et al., "Trehalose polyphleates, external cell wall lipids in Mycobacterium abscessus, are associated with the formation of clumps with cording morphology, which have been associated with virulence," Frontiers in Microbiology, vol. 8, article no. 1402, 2017.

[21] J. Han, M. A. Jyoti, H.-Y. Song, and W. S. Jang, "Antifungal activity and action mechanism of histatin 5-halocidin hybrid peptides against candida ssp," PLoS ONE, vol. 11, no. 2, Article ID e0150196, 2016.

[22] S. Yoshikawa, K. Shinzawa-Itoh, R. Nakashima et al., "Redox-coupled crystal structural changes in bovine heart cytochrome c oxidase," Science, vol. 280, no. 5370, pp. 1723-1729,1998.

[23] M. W. Bowler, M. G. Montgomery, A. G. W. Leslie, and J. E. Walker, "How azide inhibits ATP hydrolysis by the F-ATPases," Proceedings of the National Acadamy of Sciences of the United States of America, vol. 103, no. 23, pp. 8646-8649, 2006.

[24] J. M. May, Z.-C. Qu, and R. R. Whitesell, "Generation of oxidant stress in cultured endothelial cells by methylene blue: Protective effects of glucose and ascorbic acid," Biochemical Pharmacology, vol. 66, no. 5, pp. 777-784, 2003.

[25] M. I. Voskuil, I. L. Bartek, K. Visconti, and G. K. Schoolnik, "The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species," Frontiers in Microbiology, vol. 2, no. 105, 2011.

[26] C. D. Mahl, C. S. Behling, F. S. Hackenhaar et al., "Induction of ROS generation by fluconazole in Candida glabrata: Activation of antioxidant enzymes and oxidative DNA damage," Diagnostic Microbiology and Infectious Disease, vol. 82, no. 3, pp. 203-208, 2015.

[27] V. Mizrahi and S. J. Andersen, "DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence?" Molecular Microbiology, vol. 29, no. 6, pp. 1331-1339,1998.

[28] D. Jakimowicz, A. Brzostek, A. Rumijowska-Galewicz et al., "Characterization of the mycobacterial chromosome segregation protein ParB and identification of its target in Mycobacterium smegmatis," Microbiology, vol. 153, no. 12, pp. 4050-4060, 2007.

[29] J. A. Lee, N. Robbins, J. L. Xie, T. Ketela, and L. E. Cowen, "Functional Genomic Analysis of Candida albicans Adherence Reveals a Key Role for the Arp2/3 Complex in Cell Wall Remodelling and Biofilm Formation," PLoS Genetics, vol. 12, no. II, Article ID e1006452, 2016.

[30] L. Pang, X. Tian, W. Pan, and J. Xie, "Structure and function of mycobacterium glycopeptidolipids from comparative genomics perspective," Journal of Cellular Biochemistry, vol. 114, no. 8, pp. 1705-1713, 2013.

[31] N. Fujiwara, N. Ohara, M. Ogawa et al., "Glycopeptidolipid of Mycobacterium smegmatis J15cs affects morphology and survival in host cells," PLoS ONE, vol. 10, no. 5, Article ID e0126813, 2015.

[32] V. Jarlier and H. Nikaido, "Permeability barrier to hydrophilic solutes in Mycobacterium chelonei," Journal of Bacteriology, vol. 172, no. 3, pp. 1418-1423,1990.

[33] D. Portevin, C. De Sousa-D'Auria, H. Montrozier et al., "The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: Identification of the carboxylation product and determination of the acyl-CoA carboxylase components," The Journal of Biological Chemistry, vol. 280, no. 10, pp. 8862-8874, 2005.

[34] A. Milano, F. Forti, C. Sala, G. Riccardi, and D. Ghisotti, "Transcriptional regulation of furA and katG upon oxidative stress in Mycobacterium smegmatis," Journal of Bacteriology, vol. 183, no. 23, pp. 6801-6806, 2001.

[35] T. Dos Vultos, O. Mestre, T. Tonjum, and B. Gicquel, "DNA repair in Mycobacterium tuberculosis revisited," FEMS Microbiology Reviews, vol. 33, no. 3, pp. 471-487, 2009.

[36] J. Recht and R. Kolter, "Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis," Journal of Bacteriology, vol. 183, no. 19, pp. 5718-5724, 2001.

[37] J. S. Schorey and L. Sweet, "The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis," Glycobiology, vol. 18, no. 11, pp. 832-841, 2008.

[38] J. F. Staab, K. Datta, and P. Rhee, "Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicans," PLoS ONE, vol. 8, no. 11, Article ID e80842, 2013.

[39] E. Luk, M. Yang, L. T. Jensen, Y. Bourbonnais, and V. C. Culotta, "Manganese activation of superoxide dismutase 2 in the mitochondria of Saccharomyces cerevisiae," The Journal of Biological Chemistry, vol. 280, no. 24, pp. 22715-22720, 2005.

[40] L. A. McCauliff, Z. Xu, R. Li et al., "Multiple surface regions on the Niemann-pick C2 protein facilitate intracellular cholesterol transport," The Journal of Biological Chemistry, vol. 290, no. 45, pp. 27321-27331, 2015.

Rahul Pal, Moiz A. Ansari, Venkata Saibabu, Shrayanee Das, Zeeshan Fatima, and Saif Hameed

Amity Institute of Biotechnology, Amity University Haryana, Manesar, Gurugram 122413, India

Correspondence should be addressed to Zeeshan Fatima; and Saif Hameed;

Received 28 August 2017; Revised 22 December 2017; Accepted 31 December 2017; Published 31 January 2018

Academic Editor: Jose Yuste

Caption: Figure 1: Static/Cidal effect of MB. (a) Drug susceptibility of M. smegmatis observed by Resazurin method. (b) Bar graphs depicting the fungistatic (left panel) and mycobacteriostatic (right panel) nature of MB.

Caption: Figure 2: Effect of MB on cell surface phenotypes. (a) Colony morphologies of C. albicans on agar plate in absence (control) and presence of MB. (b) Relative sedimentation of C. albicans cells. Left panel shows [O.D.sub.600] for untreated (control) and MB treated cells depicted on 7-axis with respect to time (minutes) on %-axis. Right panel shows sedimentation rates expressed as percentage and normalized by considering the untreated control as 100%. Sedimentation rates are depicted on 7-axis with respect to control and MB on %-axis. (c) Colony morphologies of M. smegmatis on agar plate in absence (control) and presence of MB. (d) Cell sedimentation of M. smegmatis. Left panel shows [O.D.sub.590] of untreated (control) and cell treated with MB cells depicted on 7-axis with respect to time noted at 3 and 22 hrs on %- axis. Right panel shows sedimentation rates per hour on 7-axis of MB treated cells with respect to control on %-axis, calculated by estimating the difference in [OD.sub.590] from 0 till 22 hours per unit time interval and * depicts P value < 0.05.

Caption: Figure 3: Effect of energy depletion on PI uptake. Fluorescence microscopy of PI for the detection of membrane damage in the presence of MB and sodium azide (ATP inhibitor). Scale bar depicts 25 [micro]m for C. albicans and 15 [micro]m for M. smegmatis, respectively.

Caption: Figure 4: Effect of MB on ROS generation. Fluorescence microscopy of DCFDA for the detection of ROS formation in the presence of MB and reversion after treatment with AA (antioxidant). Scale bar depicts 20 [micro]m for C. albicans and 15 [micro]m for M. smegmatis, respectively.

Caption: Figure 5: Effect of MB on DNA damage. (a) Phenotypic susceptibility assay in presence of EtBr to assess genotoxicity in C. albicans and M. smegmatis, respectively. (b) Fluorescence microscopy of DAPI for the detection of DNA damage in the presence of MB. Scale bar depicts 15 [micro]m.

Caption: Figure 6: Effect of MB on biofilm formation. (a). Upper panel depicts the effect of MB on biofilm formation of C. albicans on polystyrene surface shown as bar graph and quantified by using MTT assay as described in material and methods. [OD.sub.450] nm is depicted on 7-axis and * depicts P value < 0.05. Lower panel depicts the effect of MB on biofilm biomass formed on silicone sheets. Biofilm dry weight is depicted on 7-axis. Inset represents inhibition in biofilm with fluorescence microscopy images of CFW stained cells in presence of MB. (b). Upper panel depicts the effect of MB on biofilm formation of M. smegmatis on polystyrene surface shown as bar graph and quantified by using MTT assay as described in material and methods. [OD.sub.450] nm is depicted on 7-axis and * depicts P value < 0.05. Lower panel depicts the effect of MB on biofilm biomass formed on silicone sheets. Biofilm dry weight is depicted on 7- axis. Inset represents inhibition in biofilm with fluorescence microscopy images of CFW stained cells in presence of MB.

Caption: Figure 7: Effect of MB on cell adherence. (a) Upper panel shows the effect of MB on cell adherence on microtiter polystyrene surface of C. albicans depicted as bar graph and quantified by using MTT assay. [OD.sub.450] nm is depicted on 7-axis and * depicts P value < 0.05. Lower panel depicts no difference in the epithelial cell adherence in the presence of MB in C. albicans. (b) Upper panel shows the effect of MB on cell adherence on microtiter polystyrene surface of M. smegmatis depicted as bar graph and quantified by using MTT assay. [OD.sub.450] nm is depicted on 7-axis and * depicts P value < 0.05. Lower panel depicts inhibited epithelial cell adherence in M. smegmatis in the presence of MB. Arrows indicate adhered cells which were absent in MB treated cells.

Caption: Figure 8: RT-PCR in response to MB. The left panels show transcript levels of lanes (1) Control (-MB), (2) MB. The right panel shows the quantitation (density expressed as intensity/[mm.sup.2]) of the respective transcripts normalized with constitutively expressed 16S and ACT1 genes for Mycobacterium and C. albicans, respectively.

Caption: Figure 9: Summary of altered mechanisms in C. albicans and M. smegmatis cells after MB treatment. Green and red color depict affected and unaffected phenotypes, respectively.
Table 1: List of primers used in the study for M. smegmatis
and C. albicans, respectively.

S. number   Gene               Sequence

1            16S       5'-GGCGAACGGGTGAGTAACA-3'
2           KATG       5'-GCCACCCAGGAAGAGACC-3'
5            GPL       5'-CATGATCCCCGAGGAGCAC-3'
6           ACT1      5'-TTTTGACCTTGAGATACCCA-3'
7           HWP1      5'-ACTACCCACAACAACCACAA-3'
8            SOD      5'-TCAGATCATCATCTCGTGTTT-3'
                      3' -TCTTCTTTCAGCTTCCTTCC-5'
9           NPC2      5'-GAACTTGGCAATTGTTACCC-3'
COPYRIGHT 2018 COPYRIGHT 2010 SAGE-Hindawi Access to Research
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Pal, Rahul; Ansari, Moiz A.; Saibabu, Venkata; Das, Shrayanee; Fatima, Zeeshan; Hameed, Saif
Publication:Journal of Pathogens
Date:Jan 1, 2018
Previous Article:Analysis of Aminoglycoside Modifying Enzyme Genes Responsible for High-Level Aminoglycoside Resistance among Enterococcal Isolates.
Next Article:Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin...

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters